Skip to main content
GIPResearch.com · Patent and Technology Research

AUDIOCURE PHARMA GmbH Received a Patent for FLUOR-9-METHYL-β-CARBOLINE

AudioCure Pharma Gmbh provides pharmaceutical services.

Save or follow this source
These actions open third-party AI services. Saving, citation, and future recall are not guaranteed.
Conceptual GIPResearch illustration for AUDIOCURE PHARMA GmbH Received a Patent for FLUOR-9-METHYL-β-CARBOLINE
Research and original publication material

AUDIOCURE PHARMA GmbH Received a Patent for FLUOR-9-METHYL-β-CARBOLINE — research background

Research context: This article preserves existing publication material for continuity. Technical, commercial and legal references should be checked against current primary sources before making decisions.

AudioCure Pharma Gmbh provides pharmaceutical services. The Company designs and develops drugs for the treatment of hearing disorders and vertigo. AudioCure Pharma primarily operates in Germany. In India, the Pharmaceutical business of AudioCure Pharma Gmbh is focused on Beta-carbolines for use in the treatment of hearing loss and vertigo. Audiocure Pahrma GmbH filed patent application numbered 201617012811 that is titled as HOLLOW CALCIUM PHOSPHATE PARTICLES. This Patent Application has been granted as Patent Number 316684. The invention covers Pharmaceuticals compound. This invention relates to fluor-9-methyl-β-carbolines, to the production thereof, to the medical use thereof, and to pharmaceutical compositions containing fluor-9-methyl-β-carbolines. During patent examination, the patent examiner raised objections under Section 3(d) of the Indian Patents Act that it is not clear if the claimed combination act to provide an enhancement of the known efficacy w.r.t the known compound or combinations thereto. As a response to the said objection, the applicant submits that the fluor-9-methyl-β-carbolines of the present invention are new and inventive. Compared to the use of oxalic acid, the use of the glyoxylic acid monohydrate has an advantage, because glyoxylic acid is easily in situ generated from the glyoxylic acid monohydrate than from oxalic acid. Advocate Rahul Dev is a Patent Attorney & International Business Lawyer practicing Technology, Intellectual Property & Corporate Laws. He is reachable at rd (at) patentbusinesslawyer (dot) com & @rdpatentlawyer on Twitter. Quoted in and contributed to 50+ national & international publications (Bloomberg, FirstPost, SwissInfo, Outlook Money, Yahoo News, Times of India, Economic Times, Business Standard, Quartz, Global Legal Post, International Bar Association, LawAsia, BioSpectrum Asia, Digital News Asia, e27, Leaders Speak, Entrepreneur India, VCCircle, AutoTech). Regularly invited to speak at international & national platforms (conferences, TV channels, seminars, corporate trainings, government workshops) on technology, patents, business strategy, legal developments, leadership & management.

Discuss a research question related to AUDIOCURE PHARMA GmbH Received a Patent for

Describe your objective and the evidence you need. The suitability and scope of any research engagement will be confirmed individually.

Discuss a research question

Source and context: Original GIPResearch.com publication dated 2019-09-30. Existing text is retained for historical continuity. Verify time-sensitive matters using official records.

None

Featured Work & Insights